Related Experiment Video
Updated: Jan 11, 2026
Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
18F-FDG versus 18F-FDOPA PET in recurrent medulloblastoma: a case study and literature review
Abarnaa Sivapathasundaram1, Florence Laigle-Donadey2, Catherine Horodyckid3
1U1146 Inserm, SU, UMR 7371 CNRS, Laboratoire d'imagerie Biomédicale, Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix, Service de Médecine Nucléaire, Sorbonne Université, 47-83 Boulevard de l'Hôpital, 75013, Paris, France.
Abstract:
Medulloblastoma is a heterogeneous central nervous system tumor stratified into four molecular subgroups in the revised 2021 WHO classification. Although MRI remains essential for follow-up, distinguishing true recurrence from treatment-related changes can be challenging. PET imaging may provide additional value in this context; however, evidence in medulloblastoma is limited to small series and case reports, with most available PET data originating from glioma studies. Here, we report a medulloblastoma patient experiencing two recurrences assessed sequentially with 18F-FDOPA and 18F-FDG PET imaging. This case highlights considerations in PET tracer selection, aiming to support clinical decision-making and enhance diagnostic accuracy for physicians managing recurrent medulloblastoma.
Insights
Distinguishing medulloblastoma recurrence from treatment effects is difficult. This case study explores 18F-FDOPA and 18F-FDG PET imaging for recurrent central nervous system tumors, aiding clinical decisions.
Area of Science:
- Neuro-oncology
- Medical imaging
- Nuclear medicine
Background:
- Medulloblastoma is a heterogeneous central nervous system tumor with four molecular subgroups (WHO 2021).
- MRI is crucial for follow-up, but differentiating true recurrence from treatment effects is challenging.
- Existing PET imaging evidence in medulloblastoma is limited, with most data from glioma studies.
Purpose of the Study:
- To evaluate the utility of sequential 18F-FDOPA and 18F-FDG PET imaging in a medulloblastoma patient with recurrent disease.
- To highlight considerations for PET tracer selection in managing recurrent medulloblastoma.
- To support clinical decision-making and improve diagnostic accuracy for physicians.
Main Methods:
- Sequential PET imaging using 18F-FDOPA and 18F-FDG.
- Assessment of a single patient with two documented recurrences of medulloblastoma.
- Clinical correlation of imaging findings with patient outcomes.
Main Results:
- The case demonstrates the sequential application of two PET tracers in recurrent medulloblastoma.
- The findings underscore the importance of careful PET tracer selection based on the clinical context.
- This case provides insights into the potential role of PET in evaluating treatment-related changes versus true tumor recurrence.
Conclusions:
- PET imaging, specifically with tracers like 18F-FDOPA and 18F-FDG, may offer valuable information in recurrent medulloblastoma.
- Careful consideration of PET tracer characteristics is essential for accurate diagnosis in this setting.
- Further research with larger cohorts is warranted to establish definitive guidelines for PET use in recurrent medulloblastoma.
More Related Videos
10:48PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
Published on: December 28, 2017
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
